Form 4: Olema Pharmaceuticals Director Granted Stock Options

Olema Pharmaceuticals, Inc. Director Gorjan Hrustanovic was granted 24,150 stock options with an exercise price of $4.08, vesting over 12 months or until the next annual meeting.

Summary

• Gorjan Hrustanovic, a Director of Olema Pharmaceuticals, Inc. (OLMA), was granted 24,150 stock options.
• The transaction date for the option grant was June 11, 2025.
• The exercise price for these stock options is $4.08 per share.
• The options vest in 12 successive equal monthly installments starting from June 11, 2025, contingent on the Reporting Person's continuous service.
• If not fully vested by the Issuer's next annual meeting of stockholders, the options will vest in full on that date, subject to continuous service.
• The expiration date for these stock options is June 11, 2035.
• The underlying security for these options is 24,150 shares of Common Stock.
• The Reporting Person is a member of BVF Partners L.P. and is obligated to transfer any economic benefit from the sale of shares upon exercise to BVF, disclaiming beneficial ownership except for pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the grant of stock options to a director aligns their interests with shareholders, which is generally viewed favorably for corporate governance and long-term performance incentives. There are no negative implications for the company from this specific filing.

Positives

• The grant of stock options to a director aligns their financial interests with those of the shareholders, incentivizing long-term company performance.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The stock options are subject to a vesting schedule over 12 successive equal monthly installments from June 11, 2025, or will vest in full on the date of the Issuer's next annual meeting of stockholders if not fully vested by then, contingent on the Reporting Person's continuous service.

Related Party Transactions

• The Reporting Person, Gorjan Hrustanovic, is a member of BVF Partners L.P. and is obligated to transfer any economic benefit received from the sale of shares upon exercise of these equity grants to BVF. This indicates a financial arrangement with a related entity.

Stakeholder Impact

• Shareholders: The grant of options to a director can align management's interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The stock options will vest according to the specified schedule, either monthly over 12 installments or in full at the next annual meeting, subject to continuous service.

Key Dates

Keywords

Olema Pharmaceuticals, OLMA, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, Vesting Schedule, BVF Partners